Items where authors include "Makris, M."

Export as [feed] Atom [feed] RSS
Jump to: Article
Number of items: 69.

Article

Hay, C.R.M. orcid.org/0000-0002-0162-6828, Makris, M. orcid.org/0000-0001-7622-7939, Shima, M. orcid.org/0000-0002-5922-7061 et al. (5 more authors) (2023) Association of patient, treatment and disease characteristics with patient‐reported outcomes: results of the ECHO registry. Haemophilia. ISSN 1351-8216

Zuberbier, T. orcid.org/0000-0002-1466-8875, Abdul Latiff, A., Aggelidis, X. orcid.org/0000-0003-1715-3022 et al. (105 more authors) (2023) A concept for integrated care pathways for atopic dermatitis—A GA2LEN ADCARE initiative. Clinical and Translational Allergy, 13 (9). e12299. ISSN 2045-7022

O'Sullivan, J.M., Tootoonchian, E., Ziemele, B. et al. (12 more authors) (2023) Von Willebrand disease: gaining a global perspective. Haemophilia. ISSN 1351-8216

Arachchillage, D.J. orcid.org/0000-0001-5993-4850, Rajakaruna, I., Odho, Z. orcid.org/0000-0002-5176-4364 et al. (2 more authors) (2023) Impact of thromboprophylaxis on hospital acquired thrombosis following discharge in patients admitted with COVID-19: Multicentre observational study in the UK. British Journal of Haematology. ISSN 0007-1048

Lacey, J., Webster, S.J., Heath, P.R. et al. (7 more authors) (2022) Sorting Nexin 24 is required for α-granule biogenesis and cargo delivery in megakaryocytes. Haematologica, 107 (8). pp. 1902-1913. ISSN 0390-6078

Chowdary, P., Shapiro, S., Makris, M. orcid.org/0000-0001-7622-7939 et al. (15 more authors) (2022) Phase 1–2 trial of AAVS3 gene therapy in patients with hemophilia B. New England Journal of Medicine, 387 (3). pp. 237-247. ISSN 0028-4793

Shapiro, S., Benson, G., Evans, G. et al. (3 more authors) (2022) Cardiovascular disease in hereditary haemophilia : the challenges of longevity. British Journal of Haematology, 197 (4). pp. 397-406. ISSN 0007-1048

Craven, B., Lester, W.A., Boyce, S. et al. (13 more authors) (2022) Natural history of PF4 antibodies in vaccine induced immune thrombocytopenia and thrombosis. Blood, 139 (16). pp. 2553-2560. ISSN 0006-4971

Klok, F.A., Pai, M., Huisman, M.V. et al. (1 more author) (2022) Vaccine-induced immune thrombotic thrombocytopenia. The Lancet Haematology, 9 (1). e73-e80. ISSN 2352-3026

Greinacher, A., Langer, F., Makris, M. orcid.org/0000-0001-7622-7939 et al. (4 more authors) (2021) Vaccine‐induced immune thrombotic thrombocytopenia (VITT) ‐ update on diagnosis and management considering different resources. Journal of Thrombosis and Haemostasis, 20 (1). pp. 149-156. ISSN 1538-7933

Arachchillage, D.J., Rajakaruna, I., Odho, Z. et al. (27 more authors) (2021) Clinical outcomes and the impact of prior oral anticoagulant use in patients with coronavirus disease 2019 admitted to hospitals in the UK — a multicentre observational study. British Journal of Haematology, 196 (1). pp. 79-94. ISSN 0007-1048

Guy, S., Kitchen, S., Makris, M. orcid.org/0000-0001-7622-7939 et al. (3 more authors) (2021) Caution in using the activated partial thromboplastin time to monitor argatroban in COVID-19 and vaccine-induced immune thrombocytopenia and thrombosis (VITT). Clinical and Applied Thrombosis/Hemostasis, 27. ISSN 1076-0296

Miesbach, W., Chowdary, P., Coppens, M. et al. (6 more authors) (2021) Delivery of AAV‐based gene therapy through haemophilia centres—A need for re‐evaluation of infrastructure and comprehensive care: A Joint publication of EAHAD and EHC. Haemophilia, 27 (6). pp. 967-973. ISSN 1351-8216

Pavord, S., Scully, M., Hunt, B.J. et al. (6 more authors) (2021) Clinical features of vaccine-induced immune thrombocytopenia and thrombosis. New England Journal of Medicine, 385 (18). pp. 1680-1689. ISSN 0028-4793

Isfordink, C.J., van Erpecum, K.J., van der Valk, M. et al. (2 more authors) (2021) Viral hepatitis in haemophilia: historical perspective and current management. British Journal of Haematology, 195 (2). pp. 174-185. ISSN 0007-1048

Riva, N., Vella, K., Hickey, K. et al. (7 more authors) (2021) The effect of DOAC‐Stop® on several oral and parenteral anticoagulants. International Journal of Laboratory Hematology, 43 (4). O171-O175. ISSN 1751-5521

Arachchillage, D., Rajakaruna, I., Odho, Z. et al. (27 more authors) (2021) Clinical outcomes and the impact of oral anticoagulants prior to diagnosis of COVID-19 on clinical outcomes in patients admitted to hospitals in the UK – a multicentre observational study. SSRN. ISSN 1556-5068 (Submitted)

Hermans, C. and Makris, M. orcid.org/0000-0001-7622-7939 (2021) Disruptive technology and hemophilia care : the multiple impacts of emicizumab. Research and Practice in Thrombosis and Haemostasis, 5 (4). e12508.

Pipe, S.W., Kaczmarek, R., Srivastava, A. et al. (3 more authors) (2021) Management of COVID‐19‐associated coagulopathy in persons with haemophilia. Haemophilia, 27 (1). pp. 41-48. ISSN 1351-8216

Gauer, J.S., Riva, N., Page, E.M. et al. (4 more authors) (2020) Effect of anticoagulants on fibrin clot structure: a comparison between vitamin K antagonists and factor Xa inhibitors. Research and Practice in Thrombosis and Haemostasis, 4 (8). pp. 1269-1281. ISSN 2475-0379

Al-Mohammad, A., Partridge, D.G., Fent, G. et al. (5 more authors) (2020) The cardiac complications of COVID-19; many publications, multiple uncertainties. Vascular Biology, 2 (1). R105-R114. ISSN 2516-5658

Miesbach, W. and Makris, M. orcid.org/0000-0001-7622-7939 (2020) COVID-19: Coagulopathy, risk of thrombosis, and the rationale for anticoagulation. Clinical and Applied Thrombosis/Hemostasis, 26. ISSN 1076-0296

Makris, M. orcid.org/0000-0001-7622-7939 (2020) Staying updated on COVID‐19 : social media to amplify science in thrombosis and haemostasis. Research and Practice in Thrombosis and Haemostasis, 4 (5). pp. 722-726. ISSN 2475-0379

Makris, M. orcid.org/0000-0001-7622-7939 (2020) Thrombopoietin receptor agonists for the treatment of inherited thrombocytopenia. Haematologica, 105 (3). pp. 536-538. ISSN 0390-6078

Swan, D., Loughran, N., Makris, M. orcid.org/0000-0001-7622-7939 et al. (1 more author) (2020) Management of bleeding and procedures in patients on antiplatelet therapy. Blood Reviews, 39. 100619. ISSN 0268-960X

Peyvandi, F., Garagiola, I., Boscarino, M. et al. (3 more authors) (2019) Real‐life experience in switching to new extended half‐life products at European haemophilia centres. Haemophilia, 25 (6). pp. 946-952. ISSN 1351-8216

Iorio, A., Stonebraker, J.S., Chambost, H. et al. (4 more authors) (2019) Establishing the prevalence and prevalence at birth of hemophilia in males : a meta-analytic approach using national registries. Annals of Internal Medicine, 171 (8). pp. 540-546. ISSN 0003-4819

Hart, D.P., Hay, C.R.M., Liesner, R. et al. (3 more authors) (2019) Perioperative laboratory monitoring in congenital haemophilia patients with inhibitors. Blood Coagulation & Fibrinolysis, 30 (7). pp. 309-323. ISSN 0957-5235

Rodeghiero, F., Pabinger, I., Ragni, M. et al. (17 more authors) (2019) Fundamentals for a systematic approach to mild and moderate inherited bleeding disorders. HemaSphere, 3 (5). e286.

Riva, N., Borg Xuereb, C., Ageno, W. et al. (2 more authors) (2019) Validation and psychometric properties of the Maltese version of the Duke Anticoagulation Satisfaction Scale (DASS). Psychology Research and Behavior Management, 12. pp. 741-752.

Makris, M. orcid.org/0000-0001-7622-7939, Iorio, A. and Lenting, P.J. (2019) Emicizumab and thrombosis : the story so far. Journal of Thrombosis and Haemostasis, 17 (8). pp. 1269-1272. ISSN 1538-7933

Miesbach, W. orcid.org/0000-0002-4506-0061, O’Mahony, B. orcid.org/0000-0001-9780-6972, Key, N.S. orcid.org/0000-0002-8930-4304 et al. (1 more author) (2019) How to discuss gene therapy for haemophilia? A patient and physician perspective. Haemophilia, 25 (4). pp. 545-557. ISSN 1351-8216

Riva, N., Borg Xuereb, C., Makris, M. orcid.org/0000-0001-7622-7939 et al. (2 more authors) (2019) Reliability and validity of the Maltese version of the perception of anticoagulant treatment questionnaire (PACT-Q). Patient Preference and Adherence, Volume 13. pp. 969-979. ISSN 1177-889X

Kitchen, S. orcid.org/0000-0002-6826-8519, Jennings, I., Makris, M. orcid.org/0000-0001-7622-7939 et al. (3 more authors) (2019) Clotting and chromogenic factor VIII assay variability in post-infusion and spiked samples containing full-length recombinant FVIII or recombinant factor VIII Fc fusion protein (rFVIIIFc). International Journal of Laboratory Hematology, 41 (2). pp. 176-183. ISSN 1751-5521

Bowyer, A., Shepherd, M.F., Kitchen, S. et al. (2 more authors) (2019) Measurement of extended half-life recombinant factor IX products in clinical practice. International Journal of Laboratory Hematology, 41 (2). e46-e49. ISSN 1751-5521

Shapiro, S. and Makris, M. orcid.org/0000-0001-7622-7939 (2019) Haemophilia and ageing. British Journal of Haematology, 184 (5). pp. 712-720. ISSN 0007-1048

Makris, M. orcid.org/0000-0001-7622-7939 and Iorio, A. orcid.org/0000-0002-3331-8766 (2019) Prehospital fresh frozen plasma: Universal life saver or treatment in search of a target population? Research and Practice in Thrombosis and Haemostasis , 3 (1). pp. 12-14. ISSN 2475-0379

Makris, M. orcid.org/0000-0001-7622-7939, Oldenburg, J., Mauser-Bunschoten, E.P. et al. (4 more authors) (2018) The definition, diagnosis and management of mild hemophilia A: communication from the SSC of the ISTH. Journal of Thrombosis and Haemostasis, 16 (12). pp. 2530-2533. ISSN 1538-7933

Makris, M. orcid.org/0000-0001-7622-7939 and Farrugia, A. (2018) Comparative analysis of marketed factor VIII products: comment. Journal of Thrombosis and Haemostasis. ISSN 1538-7933

RIva, N., Vella, K., Hickey, K. et al. (7 more authors) (2018) Biomarkers for the diagnosis of venous thromboembolism: D-dimer, thrombin generation, procoagulant phospholipid and soluble P-selectin. Journal of Clinical Pathology, 71 (11). pp. 1015-1022. ISSN 0021-9746

Johnson, B., Doak, R., Allsup, D. et al. (15 more authors) (2018) A comprehensive targeted next-generation sequencing panel for genetic diagnosis of patients with suspected inherited thrombocytopenia. Research and Practice in Thrombosis and Haemostasis, 2 (4). pp. 640-652. ISSN 2475-0379

Bowyer, A.E., Goodfellow, K.J., Seidel, H. et al. (5 more authors) (2018) Evaluation of a semi-automated von willebrand factor multimer assay, the Hydragel 5 von Willebrand multimer, by two European Centers. Research and Practice in Thrombosis and Haemostasis, 2 (4). pp. 790-799. ISSN 2475-0379

Thomas, S. and Makris, M. orcid.org/0000-0001-7622-7939 (2018) The reversal of anticoagulation in clinical practice. Clinical Medicine, 18 (4). pp. 314-319. ISSN 1470-2118

Iorio, A., Edginton, A., Blanchette, V. et al. (16 more authors) (2018) Performing and interpreting individual pharmakokinetic profiles in patients with Hemophilia A or B: rationale and general considerations. Research and Practice in Thrombosis and Hemostasis, 2 (3). pp. 535-548. ISSN 2475-0379

Collins, P., Liesner, R., Makris, M. orcid.org/0000-0001-7622-7939 et al. (7 more authors) (2018) Treatment of bleeding episodes in haemophilia A complicated by a factor VIII inhibitor in patients receiving Emicizumab. Interim guidance from UKHCDO Inhibitor Working Party and Executive Committee. Haemophilia, 24 (3). pp. 344-347. ISSN 1351-8216

Collins, P., Quon, D., Makris, M. orcid.org/0000-0001-7622-7939 et al. (9 more authors) (2018) Pharmacokinetics, safety and efficacy of a recombinant factor IX product, trenonacog alfa in previously treated haemophilia B patients. Haemophilia, 24 (1). pp. 104-112. ISSN 1351-8216

Riva, N., Vella, K., Meli, S. et al. (7 more authors) (2017) A comparative study using thrombin generation and three different INR methods in patients on vitamin K antagonist treatment. International Journal of Laboratory Hematology, 39 (5). pp. 482-488. ISSN 1751-5521

Menegatti, M., Palla, R., Boscarino, M. et al. (6 more authors) (2017) Minimal factor XIII activity level to prevent major spontaneous bleeds. Journal Of Thrombosis And Haemostasis, 15 (9). pp. 1728-1736. ISSN 1538-7933

Iorio, A., Fischer, K. and Makris, M. orcid.org/0000-0001-7622-7939 (2017) Large scale studies assessing anti-factor VIII antibody development in previously untreated haemophilia A: what has been learned, what to believe and how to learn more. British Journal of Haematology, 178 (1). pp. 20-31. ISSN 0007-1048

van Vulpen, L., Keeling, D. and Makris, M. orcid.org/0000-0001-7622-7939 (2017) Von Willebrand disease and extra-intestinal angiodysplasia. Haemophilia, 23 (4). e354-e355. ISSN 1365-2516

Makris, M. and Kessler, C.M. (2017) SIPPET trial: the answers. Haemophilia, 23 (3). pp. 344-345. ISSN 1351-8216

Korte, W., Poon, M., Iorio, A. et al. (1 more author) (2017) Thrombosis in inherited fibrinogen disorders. Transfusion Medicine and Hemotherapy, 44 (2). pp. 70-76. ISSN 1660-3796

Harrison, C., Saccullo, G. and Makris, M. orcid.org/0000-0001-7622-7939 (2017) Haemophilia of the third age. Haemophilia, 24 (1). pp. 5-16. ISSN 1351-8216

Makris, M. orcid.org/0000-0001-7622-7939 and Konkle, B.A. (2017) Hepatitis C in Haemophilia: Time for treatment for all. Haemophilia, 23 (2). pp. 180-181. ISSN 1351-8216

Iorio, A., Barbara, A., Makris, M. orcid.org/0000-0001-7622-7939 et al. (21 more authors) (2017) Natural history and clinical characteristics of inhibitors in previously treated haemophilia A patients: A case series. Haemophilia, 23 (2). pp. 255-263. ISSN 1351-8216

Saccullo, G., Bucko, A.M., Van Veen, J.J. et al. (1 more author) (2017) Why is it so difficult to show that prothrombin complex concentrates are superior to fresh-frozen plasma for warfarin reversal? Blood Transfusion, 15. pp. 277-278. ISSN 1723-2007

Daly, M.E. orcid.org/0000-0002-4597-8921, Cooper, P.C., Hickey, K.P. et al. (2 more authors) (2017) Transient inherited antithrombin deficiency: a real phenomenon? Thrombosis and Haemostasis, 117 (03). pp. 642-643. ISSN 0340-6245

van Vulpen, L., Saccullo, G., Iorio, A. et al. (1 more author) (2017) The current state of adverse event reporting in hemophilia. Expert Review of Hematology, 10 (2). pp. 161-168. ISSN 1747-4086

Kitchen, S., Jennings, I., Makris, M. orcid.org/0000-0001-7622-7939 et al. (3 more authors) (2016) Factor VIII assay variability in postinfusion samples containing full length and B-domain deleted FVIII. Haemophilia, 22 (5). pp. 806-812. ISSN 1351-8216

Ali, S., Shetty, S., Ghosh, K. et al. (5 more authors) (2016) Congenital macrothrombocytopenia is a heterogeneous disorder in India. Haemophilia, 22 (4). pp. 570-582. ISSN 1351-8216

Johnson, B., Lowe, G.C., Futterer, J. et al. (31 more authors) (2016) Whole exome sequencing identifies genetic variants in inherited thrombocytopenia with secondary qualitative function defects. Haematologica. ISSN 0390-6078

Arachchillage, D.R.J. and Makris, M. orcid.org/0000-0001-7622-7939 (2016) Choosing and using non-steroidal anti-inflammatory drugs in haemophilia. Haemophilia, 22 (2). pp. 179-187. ISSN 1351-8216

Saccullo, G. and Makris, M. orcid.org/0000-0001-7622-7939 (2016) Prophylaxis in von Willebrand Disease: Coming of Age? Seminars in Thrombosis and Hemostasis, 42 (05). pp. 498-506. ISSN 0094-6176

Fischer, K., Iorio, A., Lassila, R. et al. (8 more authors) (2015) Inhibitor development in non-severe haemophilia across Europe. Thrombosis and Haemostasis, 114 (4). pp. 670-675. ISSN 0340-6245

Fischer, K., Lassila, R., Peyvandi, F. et al. (8 more authors) (2015) Inhibitor development in haemophilia according to concentrate Four-year results from the European HAemophilia Safety Surveillance (EUHASS) project. THROMBOSIS AND HAEMOSTASIS, 113 (5). pp. 968-975. ISSN 0340-6245

Dmoszynska, A., Kuliczkowski, K., Hellmann, A. et al. (10 more authors) (2011) Clinical assessment of Optivate®, a high-purity concentrate of factor VIII with von Willebrand factor, in the management of patients with haemophilia A. Haemophilia, 17 (3). pp. 456-462. ISSN 1351-8216

Moore, T., Norman, P., Harris, P.R. et al. (1 more author) (2008) An interpretative phenomenological analysis of adaptation to recurrent venous thrombosis and heritable thrombophilia - The importance of multi-causal models and perceptions of primary and secondary control. Journal of Health Psychology, 13 (6). pp. 776-784. ISSN 1359-1053

Moore, T., Norman, P., Harris, P.R. et al. (1 more author) (2006) Cognitive appraisals and psychological distress following venous thromboembolic disease: An application of the theory of cognitive adaptation. Social Science and Medicine, 63 (9). pp. 2395-2406. ISSN 0277-9536

Moore, T., Norman, P., Harris, P.R. et al. (1 more author) (2006) Cognitive appraisals and psychological distress following venous thromboembolic disease: an application of the theory of cognitive adaptation. Social Science and Medicine, 63 (9). pp. 2395-2406. ISSN 0277-9536

This list was generated on Sun Mar 24 06:42:32 2024 GMT.